Intimate Care

Intimate care, washes, wipes, and deodorising or moisturising products for the intimate area, is a category defined by where it is applied. The Cosmetics Regulation’s definition explicitly includes the external mucous membranes, so an intimate cosmetic is firmly within scope, but application to or near mucosa changes the exposure, the microbiology and, above all, the boundary with medicines.

Mucous-membrane application

Because Article 2 brings the external mucous membranes into the definition of a cosmetic, the assessment has to treat mucosal exposure rather than ordinary skin. Three things receive particular attention. The pH matters, because the external intimate area is naturally acidic and a product is normally formulated to respect that. Irritation potential is assessed closely, given the sensitivity of the site. And for products that could reach the vaginal mucosa, osmolality is relevant, because a strongly hyperosmolar formulation can damage the epithelium. These are not optional refinements; they are central to a competent assessment of the category.

Microbiology

Intimate products are held to a strict microbiological standard given the application site, and the preservative system has to be both compliant with Annex V and proven effective by challenge testing. A mild formulation that still achieves reliable preservation is harder to build, and the safety file has to show it has been achieved.

The medicines and device line

This is the decisive issue. A product that cleanses and deodorises is a cosmetic, but a product that claims to treat thrush, bacterial vaginosis or any infection, or to restore the vaginal flora as a therapeutic effect, is a medicine and not a cosmetic. Certain lubricant, barrier or fertility-related claims can instead make a product a medical device. The category sits close enough to these regimes that the claims have to be set with real precision to keep an intended cosmetic on the cosmetic side.

Claims

Comfort and appearance claims such as pH-balanced, soothing or freshening are acceptable when evidenced, but any claim implying treatment of a condition crosses into the medicines regime. The wording is assessed alongside the formulation rather than treated as marketing copy.

How we help

We assess intimate products for mucosal exposure, pH, osmolality and irritation, hold them to the appropriate microbiological standard with a proven preservative system, and set the claims carefully so a product intended as a cosmetic does not stray into the medicine or device regimes. Where a product genuinely belongs in those regimes, we identify it early.